Strategies for the Use of Epoetin Alfa in Breast Cancer Patients

Oncologist - United States
doi 10.1634/theoncologist.3-5-314
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Darbepoetin Versus Epoetin Alfa for the Correction of Anemia in Cancer Patients Receiving Radiotherapy or Chemoradiotherapy Treatment

Clinical medicine. Oncology
2008English

Comparison of the Therapeutic Efficacy of Epoetin Beta and Epoetin Alfa in Maintenance Phase Hemodialysis Patients

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
2011English

Epoetin Alfa in Platinum-Treated Ovarian Cancer Patients: Results of a Multinational, Multicentre, Randomised Trial

British Journal of Cancer
Cancer ResearchOncology
2006English

Bioequivalence of HX575 (Recombinant Human Epoetin Alfa) and a Comparator Epoetin Alfa After Multiple Subcutaneous Administrations

Pharmacology
MedicinePharmacology
2008English

Budget Impact Analysis of Darbepoetin Alfa Every 3 Weeks Versus Epoetin Alfa Every Week for Cancer Patients Receiving Chemotherapy From a Us Payer's Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Human Choriogonadotropin and Epoetin Alfa in Acute Ischemic Stroke Patients (REGENESIS-LED Trial)

International Journal of Stroke
Neurology
2014English

Epoetin Alfa: Future Directions and Future Research

Oncologist
Cancer ResearchMedicineOncology
2004English

Immunotherapy Strategies in the Treatment of Breast Cancer

Cancer Control
MedicineOncologyHematology
2013English

Perbandingan Kualitas Hidup Pasien Yang Menjalani Hemodialisis Dengan Terapi Epoetin Alfa Dan Epoetin Beta Di RS PKU Muhammadiyah Yogyakarta

Jurnal Farmasi (Journal of Pharmacy)
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy